Central nervous system
1.1 Fremanezumab is recommended as an option for preventing migraine in adults, only if:
- the migraine is chronic, that is, 15 or more headache days a month for more than 3 months with at least 8 of those having features of migraine
- at least 3 preventive drug treatments have failed and
- the company provides it according to the commercial arrangement.